In its latest warning letter, FDA raised concern that the company was still producing eye drops with amniotic fluid, even ...

The plant manufactures two ophthalmic drug products, Regener-Eyes Professional Ophthalmic Solution and Regener-Eyes LITE Ophthalmic Solution. Regenerative distributes ophthalmic products directly to ...

The recently approved product is supplied as a single-dose (2mg of epinephrine) nasal spray that is administered into 1 nostril. Patients who do not experience improvement after a single dose may be ...

To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. European drug regulators have officially turned back a first-of-its-kind eye drug from Apellis ...

Corbus Pharmaceuticals stock fell 60%, following Novo Nordisk’s 6% drop after cannabinoid receptor drug results. Both companies develop drugs targeting the endocannabinoid system, raising ...

Workshop will be on ‘Ophthalmic Drug Delivery Development - Trials and Tribulations’. Hosted by Brian Levy, CEO, Ocunexus Therapeutics. Ophthalmic Drug Delivery is compelling for many reasons ...

This week, the Georgia Attorney General's Office dropped some of the more frivolous charges in the "Stop Cop City" case. As Reason has previously reported, state prosecutors have indicted more ...

I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness myths. On my spare time I enjoy ...

Cipro (ciprofloxacin) is a brand-name prescription drug used to treat certain bacterial infections. It can cause side effects that range from mild to serious. Examples include nausea, diarrhea ...

The total number of reported drug abusers in the first half of 2024 decreased 8% from the same period in 2023 to 3,025, the Action Committee Against Narcotics announced today. According to figures ...

Final results of the OCEAN(a)-DOSE trial – published in the New England Journal of Medicine – showed that the small, interfering RNA (siRNA) drug reduced Lp(a) levels compared to placebo at ...

Opdivo (nivolumab) is a prescription drug that’s used to treat certain types of cancer. Opdivo can cause side effects that range from mild to serious. Examples include joint pain and rash.